Skip to content

KIWA BIO-TECH PRODUCTS GROUP CORP: filings

Every KIWA BIO-TECH PRODUCTS GROUP CORP annual and quarterly report in the SEC record with the published financial measures it tagged, 39 filings, each linked to its SEC index.

Filing record ends 2020-05-29

The latest filing in this captured record is a 10-K filed 2020-05-29. No later filing is in the SEC companyfacts record captured on 2026-09-22. KIWA BIO-TECH PRODUCTS GROUP CORP may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2020-05-29fiscal FY 201951930001493152-20-010111
10-Q2019-11-14fiscal Q3 2019461340001493152-19-017301
10-Q2019-08-19fiscal Q2 2019471310001493152-19-012977
10-Q2019-05-15fiscal Q1 201945910001493152-19-007187
10-K2019-04-12fiscal FY 201845910001493152-19-005241
10-Q/A2019-03-18fiscal Q2 2017431110001493152-19-003472
10-Q/A2019-03-18fiscal Q1 201738700001493152-19-003471
10-Q2018-11-19fiscal Q3 2018461240001493152-18-016416
10-Q2018-08-14fiscal Q2 2018461220001493152-18-011683
10-Q2018-05-14fiscal Q1 201844830001493152-18-006840
10-K2018-03-30fiscal FY 201743850001493152-18-004295
10-Q2017-12-22fiscal Q3 2017461220001493152-17-014999
10-K/A2017-11-22fiscal FY 201638630001493152-17-013724
10-Q2017-08-14fiscal Q2 2017391040001493152-17-009199
10-Q2017-05-17fiscal Q1 201736690001493152-17-005533
10-K/A2017-05-03fiscal FY 201639690001493152-17-004686
10-K2017-04-17fiscal FY 201639690001493152-17-003997
10-Q2016-11-21fiscal Q3 201638940001493152-16-015332
10-Q2016-08-15fiscal Q2 201634870001493152-16-012412
10-Q2016-05-16fiscal Q1 201630580001493152-16-009871
10-K2016-04-14fiscal FY 201526530001493152-16-008900
10-Q2015-11-16fiscal Q3 201522640001615774-15-003298
10-Q2015-08-14fiscal Q2 201527770001144204-15-049753
10-Q2015-07-31fiscal Q1 201523480001615774-15-001988
10-K2015-06-29fiscal FY 201430620001144204-15-039529
10-Q2014-11-12fiscal Q3 201424700001144204-14-066794
10-Q2014-08-19fiscal Q2 201424700001144204-14-051184
10-Q2014-05-20fiscal Q1 201424500001144204-14-032252
10-K2014-03-31fiscal FY 201327560001144204-14-019098
10-Q2013-11-14fiscal Q3 201325740001144204-13-061404
10-Q2013-08-12fiscal Q2 201324700001144204-13-044572
10-Q2013-05-15fiscal Q1 201325520001144204-13-029078
10-K2013-04-15fiscal FY 201230620001144204-13-021719
10-Q2012-11-09fiscal Q3 201225720001144204-12-060589
10-Q/A2012-08-29fiscal Q2 201225720001144204-12-048496
10-Q2012-05-21fiscal Q1 201225520001144204-12-030758
10-K2012-04-06fiscal FY 201130620001144204-12-020496
10-Q2011-11-08fiscal Q3 201128760001144204-11-061805
10-Q2011-08-10fiscal Q2 201128760001144204-11-045173

Inspect the source

Entity
KIWA BIO-TECH PRODUCTS GROUP CORP / CIK 0001159275
Captured
SEC response SHA-256
074c7ef0a833d858f3545ca8e68cbd9838b9689e73d55bfdb4b8ce50c68f0c88

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001159275.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))